GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusUS GAAP · USD

GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. designs and sells medical imaging systems, patient monitoring and care equipment, and pharmaceutical diagnostics used by hospitals, health systems, researchers, and public and private healthcare institutions. The company also layers AI-enabled cloud and software tools, plus service contracts and consumables, onto its installed base to support diagnosis, treatment, and workflow efficiency across more than 160 countries.

Revenue20.6bn USD
+4.8 %y/y
Operating profit (EBIT)2,763m USD
+5.3 %y/y
EBIT margin13.4%
+0.1 ppy/y
Net income2,084m USD
+4.6 %y/y

Fiscal year 2025 · change from previous year

Development 2021–2025

0510152025bn USD2021: 17.6 bn USD2021: EBIT 2.8 bn USD20212022: 18.3 bn USD2022: EBIT 2.5 bn USD20222023: 19.6 bn USD2023: EBIT 2.4 bn USD20232024: 19.7 bn USD2024: EBIT 2.6 bn USD20242025: 20.6 bn USD2025: EBIT 2.8 bn USD202520.62.8
RevenueOperating profit (EBIT)

Business

Share of revenue
Imaging40 %

Core diagnostic imaging systems and related product lines such as MI/CT and MR.

Advanced Visualization Solutions (AVS)22 %

Ultrasound and advanced visualization tools used to improve diagnosis and clinical workflow.

Patient Care Solutions (PCS)18 %

Monitoring, life support, and care delivery equipment used in acute care settings.

Pharmaceutical Diagnostics (PDx)15 %

Contrast media and diagnostic agents used in imaging procedures and related workflows.

Software, AI, and Services5 %

Cloud software, SaaS, maintenance, upgrades, and other service capabilities.

Products

Reported · share of revenue
66.2%33.8%FY2025100 %
  • Products66.2 %
  • Services33.8 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

GE HealthCare sells primarily to hospitals, health systems, and research institutions that need capital equipment, diagnostics, and long-term service support. Its customer base also includes public, private, academic, and government buyers, with purchasing decisions driven by clinical performance, reliability, service coverage, and integration into existing IT and care workflows.

Hospitals and health systems

Buy imaging, monitoring, and care equipment plus service contracts to support daily clinical operations.

Public, private, and academic institutions

Purchase diagnostic systems and software for clinical care, teaching, and research use.

Government and procurement-driven healthcare buyers

Buy through formal tenders and reimbursement-linked purchasing processes, especially for large systems.

Installed-base customers

Buy consumables, maintenance, upgrades, and SaaS to extend the life and utility of existing systems.

Emerging digital health adopters

Adopt AI, cloud, and software tools to improve workflow, precision, and data connectivity.

Strategy

GE HealthCare is focused on pairing its installed base of hardware with recurring service, consumables, and software revenue, while investing in AI, cloud, and edge-enabled products. Management also emphasizes global commercial coverage, strategic account relationships, and product innovation to defend share against large competitors and to deepen customer relationships.

Grow AI-enabled software and cloud offeringsMedium term

Software can increase differentiation, improve workflow value, and add recurring revenue on top of hardware sales.

Increase installed-base monetizationShort term

Maintenance, upgrades, and consumables improve customer stickiness and smooth revenue through the cycle.

Strengthen global commercial executionShort term

Broad sales and service coverage is essential for winning large accounts and supporting equipment uptime.

Defend and expand in key regionsMedium term

USCAN and EMEA are major revenue pools, while China requires careful management due to pressure.

Geography

2025

GE HealthCare operates globally and serves customers in over 160 countries, with commercial reach supported by about 9,700 sales professionals and 8,900 field service engineers. Reported regional revenue is concentrated in USCAN and EMEA, while China remains a meaningful but pressured market and Rest of World provides additional growth and diversification.

Other countries (US filing)46 %
United States44 %
China9.8 %

Share of the revenue the company reports by geography.

Risks

The company faces intense competition, regulatory scrutiny, and cyclicality in healthcare capital spending, all of which can pressure pricing and order timing. Its business is also exposed to supply chain disruptions, cybersecurity threats, and execution risk around R&D-heavy bets in AI, cloud, and software, while China remains a notable geographic headwind.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Healthcare cost containment and reimbursement pressure1Supply chain and manufacturing disruption2Intense competition across imaging, diagnostics, and monitoring3Cybersecurity and product software vulnerability4China market pressure and geopolitical instability5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Healthcare cost containment and reimbursement pressureImpact: HighLikelihood: High

    Public and private payers may limit spending, reducing demand for new equipment and services.

    Exposure: Hospital and health-system purchasing

  2. Supply chain and manufacturing disruptionImpact: HighLikelihood: High

    The company relies on components, raw materials, and production facilities to meet customer delivery schedules.

    Exposure: Global manufacturing and third-party suppliers

  3. Intense competition across imaging, diagnostics, and monitoringImpact: HighLikelihood: Medium

    Large global peers compete on technology, service, price, and brand, which can erode share or margins.

    ExposureImagingAVSPCSPDx
  4. Cybersecurity and product software vulnerabilityImpact: HighLikelihood: Medium

    Connected devices and cloud software create exposure to cyberattacks, service disruption, and data loss.

    ExposureAICloudSoftwareConnected medical devices
  5. China market pressure and geopolitical instabilityImpact: MediumLikelihood: Medium

    Regional weakness and broader geopolitical uncertainty can affect demand, pricing, and supply chains.

    Exposure: China and cross-border operations

Accounting

Judgemental items
Revenue recognition and variable consideration

Sales incentives, discounts, returns, rebates, and credits reduce recognized revenue and require estimates.

Impact: Affects reported revenue timing and gross margin

Bundled equipment, service, and SaaS arrangements

Multiple performance obligations can shift revenue between upfront and over-time recognition.

Impact: Affects quarterly comparability and recurring revenue mix

Seasonality

Management says fourth-quarter revenue, operating profit, and cash flow have historically been higher.

Impact: Makes interim periods less comparable

Acquisition accounting for NMP

The acquisition and remeasurement of the remaining interest affected other income and asset values.

Impact: Can create non-operating gains or valuation adjustments

Pension, income taxes, and asset valuation estimates

These estimates can materially change earnings when assumptions or tax positions move.

Impact: Affects net income and balance sheet carrying values

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

GE HealthCare Technologies Inc. (GEHC) Revenue, Earnings & Financials 2025 – Clarifo